Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Epacadostat
2. Incb024360
1. 914471-09-3
2. Incb024360
3. Ido5l
4. Incb024360 Analogue
5. Incb14943
6. Incb 024360-analog
7. Chembl584991
8. 4-amino-n-(3-chloro-4-fluorophenyl)-n'-hydroxy-1,2,5-oxadiazole-3-carboxamidine
9. 1,2,5-oxadiazole-3-carboximidamide, 4-amino-n'-(3-chloro-4-fluorophenyl)-n-hydroxy-
10. 4-amino-n'-(3-chloro-4-fluorophenyl)-n-hydroxy-1,2,5-oxadiazole-3-carboximidamide
11. 2hr315841w
12. 1,2,5-oxadiazole-3-carboximidamide, 4-amino-n-(3-chloro-4-fluorophenyl)-n'-hydroxy-
13. 914471-09-3 (incb14943)
14. (4e)-4-[(3-chloro-4-fluoroanilino)-nitrosomethylidene]-1,2,5-oxadiazol-3-amine
15. (e)-4-amino-n'-(3-chloro-4-fluorophenyl)-n-hydroxy-1,2,5-oxadiazole-3-carboximidamide
16. Unii-2hr315841w
17. Ido Inhibitor 5l
18. Incb024360-analog
19. 4-amino-n-(3-chloro-4-fluorophenyl)-n'-hydroxy-1,2,5-oxadiazole-3 -carboximidamide
20. Schembl149779
21. Schembl16933189
22. Schembl17679343
23. Schembl19654569
24. Schembl19808082
25. Bdbm347045
26. Hms3653h15
27. Bcp08453
28. Ex-a2076
29. Bdbm50235921
30. Bdbm50300305
31. Nsc785571
32. S7587
33. Us10202388, Ref. B
34. Zinc45319649
35. Akos005266714
36. Akos026750581
37. Akos027470329
38. Akos030228677
39. Akos032947263
40. Akos037515499
41. Zinc135817512
42. Zinc198540724
43. Ccg-267172
44. Cs-1495
45. Nsc-785571
46. Sb18974
47. Ncgc00386366-01
48. Ac-33015
49. As-35126
50. As-35229
51. Da-33529
52. Hy-15683
53. Ft-0700504
54. Sw219363-1
55. J3.435.401d
56. A13004
57. Indoleamine-2,3-dioxygenase Inhibitor Incb024360
58. Q27254756
59. 4-amino-n-(3-chloro-4-fluorophenyl)-n''-hydroxy-1,2,5-oxadiazole-3-carboximidamide
60. 4-amino-n-(3-chloro-4-fluorophenyl)-n-hydroxy-1,2,5-oxadiazole-3 -carboximidamide
61. Iuu
| Molecular Weight | 271.63 g/mol |
|---|---|
| Molecular Formula | C9H7ClFN5O2 |
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Exact Mass | 271.0272303 g/mol |
| Monoisotopic Mass | 271.0272303 g/mol |
| Topological Polar Surface Area | 110 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 321 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Indoleamine 2,3-dioxygenase manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Indoleamine 2,3-dioxygenase, including repackagers and relabelers. The FDA regulates Indoleamine 2,3-dioxygenase manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Indoleamine 2,3-dioxygenase API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Indoleamine 2,3-dioxygenase supplier is an individual or a company that provides Indoleamine 2,3-dioxygenase active pharmaceutical ingredient (API) or Indoleamine 2,3-dioxygenase finished formulations upon request. The Indoleamine 2,3-dioxygenase suppliers may include Indoleamine 2,3-dioxygenase API manufacturers, exporters, distributors and traders.
Indoleamine 2,3-dioxygenase Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Indoleamine 2,3-dioxygenase GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Indoleamine 2,3-dioxygenase GMP manufacturer or Indoleamine 2,3-dioxygenase GMP API supplier for your needs.
A Indoleamine 2,3-dioxygenase CoA (Certificate of Analysis) is a formal document that attests to Indoleamine 2,3-dioxygenase's compliance with Indoleamine 2,3-dioxygenase specifications and serves as a tool for batch-level quality control.
Indoleamine 2,3-dioxygenase CoA mostly includes findings from lab analyses of a specific batch. For each Indoleamine 2,3-dioxygenase CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Indoleamine 2,3-dioxygenase may be tested according to a variety of international standards, such as European Pharmacopoeia (Indoleamine 2,3-dioxygenase EP), Indoleamine 2,3-dioxygenase JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Indoleamine 2,3-dioxygenase USP).
LOOKING FOR A SUPPLIER?
